# Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

> **NCT03803436** · PHASE2 · UNKNOWN · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 22 (estimated)

## Conditions studied

- Liver Metastases
- Colorectal Cancer Metastatic
- Liver Neoplasm
- Neoplasms

## Interventions

- **PROCEDURE:** Liver transplant
- **DRUG:** Chemotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03803436
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-02
- **Primary completion:** 2024-01
- **Final completion:** 2024-01
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2023-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03803436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03803436, "Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03803436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*